Technical Analysis for CABA - Cabaletta Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.26 | -11.02% | -0.28 |
CABA closed down 11.02 percent on Wednesday, November 20, 2024, on 2.27 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Down 10% | about 18 hours ago |
| 60 Minute Opening Range Breakdown | about 19 hours ago |
| 2x Volume Pace | about 21 hours ago |
| 3x Volume Pace | about 21 hours ago |
| 1.5x Volume Pace | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Autoimmune Disease Antibodies Autoimmunity T Cell Sjögren Syndrome
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Autoimmune Disease Antibodies Autoimmunity T Cell Sjögren Syndrome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.35 |
| 52 Week Low | 2.18 |
| Average Volume | 1,096,124 |
| 200-Day Moving Average | 10.30 |
| 50-Day Moving Average | 4.12 |
| 20-Day Moving Average | 3.81 |
| 10-Day Moving Average | 3.62 |
| Average True Range | 0.40 |
| RSI (14) | 25.37 |
| ADX | 20.31 |
| +DI | 13.42 |
| -DI | 42.46 |
| Chandelier Exit (Long, 3 ATRs) | 3.54 |
| Chandelier Exit (Short, 3 ATRs) | 3.39 |
| Upper Bollinger Bands | 5.14 |
| Lower Bollinger Band | 2.48 |
| Percent B (%b) | -0.08 |
| BandWidth | 69.85 |
| MACD Line | -0.41 |
| MACD Signal Line | -0.20 |
| MACD Histogram | -0.2017 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.92 | ||||
| Resistance 3 (R3) | 2.97 | 2.79 | 2.81 | ||
| Resistance 2 (R2) | 2.79 | 2.63 | 2.77 | 2.77 | |
| Resistance 1 (R1) | 2.53 | 2.52 | 2.44 | 2.48 | 2.74 |
| Pivot Point | 2.35 | 2.35 | 2.31 | 2.33 | 2.35 |
| Support 1 (S1) | 2.09 | 2.19 | 2.00 | 2.04 | 1.78 |
| Support 2 (S2) | 1.91 | 2.08 | 1.89 | 1.75 | |
| Support 3 (S3) | 1.65 | 1.91 | 1.71 | ||
| Support 4 (S4) | 1.60 |
